Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 40 days ago
Share
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
8 patients around the world
Available in
Argentina
Hoffmann-La Roche
2
Research sites
8
Patients around the world
This study is for people with
Neuromyelitis optica
Requirements for the patient
To 11 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Clínica Universitaria Privada Reina Fabiola - Córdoba
Recruiting
View site
Oncativo 1248, X5004FHP Córdoba, Argentina
Clínica Universitaria Privada Reina Fabiola - Córdoba
Recruiting
View site
Oncativo 1248, X5004FHP Córdoba, Argentina
Hospital de Pediatría Dr. Juan P. Garrahan
Recruiting
View site
Combate de los Pozos 1881, CABA, Buenos Aires
Hospital de Pediatría Dr. Juan P. Garrahan
Recruiting
View site
Combate de los Pozos 1881, CABA, Buenos Aires
See details
Contact us
Contact us
Study
SAkuraSun
Sponsor
Hoffmann-La Roche
Conditions
Neuromyelitis optica
Requirements
To 11 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05199688
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent